hotspot -WSS

hotspot

author：hotspot 2025-09-28 00:49:24 - browse：1869

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Eating disorder hotline's move to chatbot carried cost for volunteers

WSS

Three issues to watch in global health in 2024

UnitedHealth wins $3.3 billion takeover of Amedisys

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Tuskegee Airman Raymond Cassagnol dies at 102

Tuskegee Airman Raymond Cassagnol dies at 102

leisure time

hotspot

knowledge

What does generative AI mean for health care? We asked experts

Risky weight loss products often used by teens globally, per study

As demand for Covid shots wanes, Moderna seeks its next success

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

At least 13 dead in Texas as scorching temps continue

Thousands protest in Iraq for a second day over burning of Quran in Sweden

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Supreme Court rules employers must be more accommodating of religious observance

Peter Hotez and the public health issue of online harassment

Caregivers of transplant patients call for more support, training

Wikipedia

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

How I ended up pumping milk in a bathroom stall at JPM 2024

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

As JPM 2024 winds down, some health tech firms project optimism

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Health and fitness trackers are measuring the wrong things

explore

knowledge

leisure time

hotspot